221 related articles for article (PubMed ID: 28318807)
1. MicroRNA-302d targets IRF9 to regulate the IFN-induced gene expression in SLE.
Smith S; Fernando T; Wu PW; Seo J; Ní Gabhann J; Piskareva O; McCarthy E; Howard D; O'Connell P; Conway R; Gallagher P; Molloy E; Stallings RL; Kearns G; Forbess L; Ishimori M; Venuturupalli S; Wallace D; Weisman M; Jefferies CA
J Autoimmun; 2017 May; 79():105-111. PubMed ID: 28318807
[TBL] [Abstract][Full Text] [Related]
2. Type I Interferon Inhibition of MicroRNA-146a Maturation Through Up-Regulation of Monocyte Chemotactic Protein-Induced Protein 1 in Systemic Lupus Erythematosus.
Qu B; Cao J; Zhang F; Cui H; Teng J; Li J; Liu Z; Morehouse C; Jallal B; Tang Y; Guo Q; Yao Y; Shen N
Arthritis Rheumatol; 2015 Dec; 67(12):3209-18. PubMed ID: 26315540
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins.
Tang Y; Luo X; Cui H; Ni X; Yuan M; Guo Y; Huang X; Zhou H; de Vries N; Tak PP; Chen S; Shen N
Arthritis Rheum; 2009 Apr; 60(4):1065-75. PubMed ID: 19333922
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK/STAT signaling pathway.
Mukherjee A; Di Bisceglie AM; Ray RB
J Virol; 2015 Mar; 89(6):3356-65. PubMed ID: 25589644
[TBL] [Abstract][Full Text] [Related]
5. Identification of Cyclin-Dependent Kinase 1 as a Novel Regulator of Type I Interferon Signaling in Systemic Lupus Erythematosus.
Wu L; Qin Y; Xia S; Dai M; Han X; Wu Y; Zhang X; Ma J; Wang Y; Tang Y; Liu Z; Zhu W; Jallal B; Yao Y; Qu B; Shen N
Arthritis Rheumatol; 2016 May; 68(5):1222-32. PubMed ID: 26663909
[TBL] [Abstract][Full Text] [Related]
6. Oxidative DNA Damage Accelerates Skin Inflammation in Pristane-Induced Lupus Model.
Tumurkhuu G; Chen S; Montano EN; Ercan Laguna D; De Los Santos G; Yu JM; Lane M; Yamashita M; Markman JL; Blanco LP; Kaplan MJ; Shimada K; Crother TR; Ishimori M; Wallace DJ; Jefferies CA; Arditi M
Front Immunol; 2020; 11():554725. PubMed ID: 33072095
[TBL] [Abstract][Full Text] [Related]
7. An update on the role of type I interferons in systemic lupus erythematosus and Sjögren's syndrome.
Thorlacius GE; Wahren-Herlenius M; Rönnblom L
Curr Opin Rheumatol; 2018 Sep; 30(5):471-481. PubMed ID: 29889694
[TBL] [Abstract][Full Text] [Related]
8. Expression characteristics of interferon-stimulated genes and possible regulatory mechanisms in lupus patients using transcriptomics analyses.
Deng Y; Zheng Y; Li D; Hong Q; Zhang M; Li Q; Fu B; Wu L; Wang X; Shen W; Zhang Y; Chang J; Song K; Liu X; Shang S; Cai G; Chen X
EBioMedicine; 2021 Aug; 70():103477. PubMed ID: 34284174
[TBL] [Abstract][Full Text] [Related]
9. Unphosphorylated ISGF3 drives constitutive expression of interferon-stimulated genes to protect against viral infections.
Wang W; Yin Y; Xu L; Su J; Huang F; Wang Y; Boor PPC; Chen K; Wang W; Cao W; Zhou X; Liu P; van der Laan LJW; Kwekkeboom J; Peppelenbosch MP; Pan Q
Sci Signal; 2017 Apr; 10(476):. PubMed ID: 28442624
[TBL] [Abstract][Full Text] [Related]
10. ADAR1 Suppresses Interferon Signaling in Gastric Cancer Cells by MicroRNA-302a-Mediated IRF9/STAT1 Regulation.
Jiang L; Park MJ; Cho CJ; Lee K; Jung MK; Pack CG; Myung SJ; Chang S
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867271
[TBL] [Abstract][Full Text] [Related]
11. EZH2 Inhibition Interferes With the Activation of Type I Interferon Signaling Pathway and Ameliorates Lupus Nephritis in NZB/NZW F1 Mice.
Wu L; Jiang X; Qi C; Zhang C; Qu B; Shen N
Front Immunol; 2021; 12():653989. PubMed ID: 33868295
[TBL] [Abstract][Full Text] [Related]
12. SCD2-mediated cooperative activation of IRF3-IRF9 regulatory circuit controls type I interferon transcriptome in CD4
Kanno T; Miyako K; Nakajima T; Yokoyama S; Sasamoto S; Asou HK; Ohara O; Nakayama T; Endo Y
Front Immunol; 2022; 13():904875. PubMed ID: 36059459
[TBL] [Abstract][Full Text] [Related]
13. Expression regulation of zebrafish interferon regulatory factor 9 by promoter analysis.
Shi J; Zhang YB; Zhang JS; Gui JF
Dev Comp Immunol; 2013 Dec; 41(4):534-43. PubMed ID: 23916490
[TBL] [Abstract][Full Text] [Related]
14. Increase of viral hemorrhagic septicemia virus growth by knockout of IRF9 gene in Epithelioma papulosum cyprini cells.
Kim MS; Shin MJ; Kim KH
Fish Shellfish Immunol; 2018 Dec; 83():443-448. PubMed ID: 30244086
[TBL] [Abstract][Full Text] [Related]
15. The type I interferon-alpha mediates a more severe neurological disease in the absence of the canonical signaling molecule interferon regulatory factor 9.
Hofer MJ; Li W; Lim SL; Campbell IL
J Neurosci; 2010 Jan; 30(3):1149-57. PubMed ID: 20089923
[TBL] [Abstract][Full Text] [Related]
16. Monocyte surface expression of Fcgamma receptor RI (CD64), a biomarker reflecting type-I interferon levels in systemic lupus erythematosus.
Li Y; Lee PY; Kellner ES; Paulus M; Switanek J; Xu Y; Zhuang H; Sobel ES; Segal MS; Satoh M; Reeves WH
Arthritis Res Ther; 2010; 12(3):R90. PubMed ID: 20478071
[TBL] [Abstract][Full Text] [Related]
17. A novel type I IFN-producing cell subset in murine lupus.
Lee PY; Weinstein JS; Nacionales DC; Scumpia PO; Li Y; Butfiloski E; van Rooijen N; Moldawer L; Satoh M; Reeves WH
J Immunol; 2008 Apr; 180(7):5101-8. PubMed ID: 18354236
[TBL] [Abstract][Full Text] [Related]
18. Type I IFN signature in childhood-onset systemic lupus erythematosus: a conspiracy of DNA- and RNA-sensing receptors?
Wahadat MJ; Bodewes ILA; Maria NI; van Helden-Meeuwsen CG; van Dijk-Hummelman A; Steenwijk EC; Kamphuis S; Versnel MA
Arthritis Res Ther; 2018 Jan; 20(1):4. PubMed ID: 29321042
[TBL] [Abstract][Full Text] [Related]
19. Integrated analysis of mRNA, microRNA and protein in systemic lupus erythematosus-specific induced pluripotent stem cells from urine.
Tang D; Chen Y; He H; Huang J; Chen W; Peng W; Lu Q; Dai Y
BMC Genomics; 2016 Jul; 17():488. PubMed ID: 27402083
[TBL] [Abstract][Full Text] [Related]
20. IRF9 Prevents CD8
Huber M; Suprunenko T; Ashhurst T; Marbach F; Raifer H; Wolff S; Strecker T; Viengkhou B; Jung SR; Obermann HL; Bauer S; Xu HC; Lang PA; Tom A; Lang KS; King NJC; Campbell IL; Hofer MJ
J Virol; 2017 Nov; 91(22):. PubMed ID: 28878077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
